You are here

Article Text

Article menu
Download PDFPDF
Correspondence
Rheumatic disease and COVID-19
  1. Jean W Liew1,
  2. Elizabeth R Graef2
  1. 1 Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington, USA
  2. 2 Department of Rheumatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
  1. Correspondence to Dr Jean W Liew, Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA 98195, USA; liew.jw{at}gmail.com

https://doi.org/10.1136/annrheumdis-2020-217674

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We appreciated the letter from Monti et al, which was the first dedicated report of patients with rheumatic disease who have been diagnosed with COVID-19.1 We have also reviewed the response from Joob and Wiwanitkit,2 which unfortunately perpetuates the notion that individuals with systemic lupus erythematosus (SLE) or other rheumatic disease may be protected from COVID-19 infection via hydroxychloroquine use. Although the origins of this claim are not entirely clear, they may arise from the fact that rheumatic or autoimmune diseases were not initially reported among other comorbidities in the first large Chinese case series.3–5 Some of …

    View Full Text

    Footnotes

    • Twitter @rheum_cat, @situationrheum

    • Correction notice This article has been corrected since it published Online First. The second affiliation has been corrected.

    • Contributors Both authors contributed to this work.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.